Concepedia

John P. Broskey

JP

6

Publications

360

Citations

6

H-Index

2000

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

South College

GlaxoSmithKline (Croatia)

John P. Broskey is an author at GlaxoSmithKline (United States) specializing in clinical microbiology, drug resistance, and antibiotics.

Top concepts

Publications per year

2000–2016

6

Publications

6

Selection of Retapamulin, a Novel Pleuromutilin for Topical Use

Stephen Rittenhouse, Sanjoy Kanti Biswas, John P. Broskey et al. · Antimicrobial Agents and Chemotherapy · 2006 · 91 citations · Full text

, , +18

Inhibitors of Pantothenate Kinase: Novel Antibiotics for Staphylococcal Infections

Anthony E. Choudhry, Tracy Mandichak, John P. Broskey et al. · Antimicrobial Agents and Chemotherapy · 2003 · 89 citations · Full text

The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulence The GenBank accession number for the sequence reported in this paper is AF228662.

Alison F. Chalker, Karen Ingraham, R. Dwayne Lunsford et al. · Microbiology · 2000 · 81 citations

, , +19

Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae

John P. Broskey · Journal of Antimicrobial Chemotherapy · 2000 · 53 citations · Full text

, , +16

6-Alkylquinolone-3-carboxylic acid tethered to macrolides synthesis and antimicrobial profile

Samra Kapić, Hana Čipčić Paljetak, Sulejman Alihodžić et al. · Bioorganic & Medicinal Chemistry · 2010 · 24 citations

, , +5

Rows per page

1–5 of 6